$VISLBullishMed

Vedanta Lists Four Independent Companies on BSE and NSE

Vedanta Group listed four demerged companies—Vedanta Aluminium, Vedanta Oil & Gas, Vedanta Iron & Steel, and Vedanta Power—on India’s BSE and NSE, with trading starting today alongside Vedanta Limited. The firms cover metals, critical minerals, oil & gas, power, and iron & steel, according to Vedanta. The article cites plans including Vedanta Aluminium capacity to 60 lakh tonnes by 3 years, Oil & Gas investment of about $5bn to 500,000 bpd, Iron & Steel to 15 mtpa, and Power to 20 GW.

7/10
6/10
Med
Bullish
begins trading today (first-day demerger listings)
positive-to-neutral; growth/capex targets for the spun entities could support risk-on positioning

Capacity expansion plan and input security narrative can support a re-rating of standalone steel growth optionality.

Vedanta Iron & Steel starts trading today, with a roadmap to scale steel capacity from ~4 million tonnes to 15 million tonnes per annum.

Moderately positive near-term reaction possible as markets price the growth runway and integrated input advantages.

Background

Vedanta Group has demerged into four sector-focused companies and is listing them on BSE/NSE, with Vedanta Limited remaining the flagship listed entity.

Why it matters

First-day trading of newly demerged entities can trigger re-pricing (sum-of-the-parts) and investor rotation between the parent and the standalone businesses, especially given the article’s explicit capacity and capex targets.

Market relevance

This is a demerger/listing event with concrete growth targets for each spun entity, which can drive valuation and positioning changes on first trading day.

Market effects

Creates four standalone, sector-focused vehicles (aluminium, upstream oil & gas, steel, power) that can concentrate investor flows and sharpen sector-specific valuation benchmarks in India’s industrial complex.

Likely increases Mumbai/Indian exchange activity and liquidity dispersion across new listings versus the parent holding company.

Global commodity-linked narratives (aluminium, steel, hydrocarbons, power) may attract international investors seeking India industrial exposure with clearer standalone risk profiles.

Alternative perspectives

Standalone listings may not automatically translate into higher value; markets could discount execution risk, capex intensity, and commodity-cycle sensitivity versus the parent’s diversified risk balance.

The article is heavy on strategic ambition; traders should separately assess regulatory/operational readiness for capacity ramps, financing details behind capex, and how demerger mechanics affect ownership, float, and index inclusion.

Key entities

  • Vedanta Limited

    Flagship listed entity that the four newly demerged companies begin trading alongside.

  • Vedanta Aluminium

    Standalone aluminium producer starting trading today; plans to double capacity to 60 lakh tonnes per annum over three years.

  • Vedanta Oil & Gas

    Standalone upstream oil & gas entity starting trading today; targets ~US$5B capex to reach 500,000 bpd.

  • Vedanta Iron & Steel

    Standalone steel entity starting trading today; roadmap to scale capacity to 15 million tonnes per annum.

  • Vedanta Power

    Standalone power entity starting trading today; roadmap to scale to 20 GW from 4.2 GW operational capacity.

Related articles

$CECOMed

5 Stock Setups Where Wall Street Sees the Most Upside Right Now

The article lists five “upside” stock calls from Wall Street. JPMorgan initiated CECO Environmental (CECO) with a $130 target, citing AI data center demand and Thermon. It also targets PRM at $50. Goldman upgraded Toast (TOST) to Buy at $36. BofA raised Ligand (LGND) target to $388. Revolution Medicines (RVMD) reported Phase 3 pancreatic cancer results for daraxonrasib, with median OS 13.2 vs 6.7 months.

$MGNMedAI 8/10

Bronstein, Gewirtz & Grossman LLC Urges Megan Holdings Limited Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC said it filed a securities class action against Megan Holdings Limited (NASDAQ: MGN) and certain officers. The suit alleges misleading statements and omissions tied to Megan’s Sept. 26, 2025 IPO and trading through Mar. 25, 2026, including claims of market manipulation and internal control weaknesses. Investors are urged to join by Sept. 8, 2026.

$MUMedAI 8/10

Why Micron Technology (MU) Is Securing Long-Term AI Memory Demand With $22 Billion in Customer Commitments

Micron Technology (MU) said June 24 it has 16 strategic customer agreements totaling $22 billion in commitments to secure memory-chip supply, including take-or-pay terms, cash deposits, and pricing floors, according to Reuters. Micron reported quarterly revenue of $41.46 billion and adjusted EPS of $25.11, citing AI demand and supply constraints beyond 2027.

$FCELMed

A $225 Million Reason to Sell FuelCell Energy Stock Now

FuelCell Energy is expanding its Torrington manufacturing facility to support up to 500 MW annualized production, with estimated expansion costs of $200 to $275 million. The company has about $441 million in cash. Analysts project EPS losses narrowing to $1.84 this fiscal year and $1.56 next. B. Riley, Jefferies, and UBS raised ratings and price targets after a Fit Energy USA data center power deployment agreement.

$IONSHighAI 8/10

Panic grips Ionis Pharmaceuticals investors amid bad news spree

Ionis Pharmaceuticals (IONS) shares fell sharply after two consecutive setbacks. On July 9, Ionis and AstraZeneca said the Phase 3 eplontersen (Wainua) trial for ATTR-CM failed its primary goal. On July 10, Roche ended two Huntington’s programs with Ionis, including tominersen. IONS dropped about 24% then another 8%, while analysts cut price targets but largely kept Buy ratings.